CD30 expression in de novo diffuse large B-cell lymphoma: a population-based study from British Columbia (Q42199195)

18 October 2017

CD30 expression in de novo diffuse large B-cell lymphoma: a population-based study from British Columbia (English)

1 reference

diffuse large B-cell lymphoma

18 October 2017

1 reference

1 reference

4

Randy D Gascoyne

1 reference

18 October 2017

Graham W Slack

1

1 reference

18 October 2017

Christian Steidl

series ordinal

2

1 reference

18 October 2017

Laurie H Sehn

series ordinal

3

1 reference

18 October 2017

language of work or name

English

0 references

publication date

19 August 2014

1 reference

British Journal of Haematology

18 October 2017

1 reference

18 October 2017

167

1 reference

18 October 2017

5

1 reference

18 October 2017

608-617

1 reference

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

18 October 2017

1 reference

EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru

21 January 2018

1 reference

Frequency and extent of CD30 expression in diffuse large B-cell lymphoma and its relation to clinical and biologic factors: a retrospective study of 167 cases

21 January 2018

1 reference

CD30 in normal and neoplastic cells.

21 January 2018

1 reference

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

21 January 2018

1 reference

An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival

21 January 2018

1 reference

U.S. Food and Drug Administration approval summary: brentuximab vedotin for the treatment of relapsed Hodgkin lymphoma or relapsed systemic anaplastic large-cell lymphoma.

21 January 2018

1 reference

Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

21 January 2018

1 reference

Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype

21 January 2018

1 reference

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations

21 January 2018

1 reference

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

21 January 2018

1 reference

CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity

21 January 2018

1 reference

Stromal gene signatures in large-B-cell lymphomas

21 January 2018

1 reference

Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma.

21 January 2018

1 reference

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab

21 January 2018

1 reference

EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation.

21 January 2018

1 reference

The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma

21 January 2018

1 reference

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.

21 January 2018

1 reference

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia

21 January 2018

1 reference

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

21 January 2018

1 reference

Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells

21 January 2018

1 reference

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

21 January 2018

1 reference

BCL6 represses NFκB activity in diffuse large B-cell lymphomas

21 January 2018

1 reference

Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.13085

1 reference

18 October 2017

1 reference